Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone

Amiel Z. Rudavsky, Leonard M. Freeman

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine <sup>131</sup>I and recombinant human thyroid stimulating hormone'. Together they form a unique fingerprint.